creatine has been researched along with Local Neoplasm Recurrence in 39 studies
Excerpt | Relevance | Reference |
---|---|---|
"Thirteen patients with recurrent glioblastoma were enrolled in RTOG 0625/ACRIN 6677, a prospective multicenter trial in which bevacizumab was used in combination with either temozolomide or irinotecan." | 5.17 | Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. ( Barboriak, DP; Bokstein, F; Boxerman, JL; Gilbert, MR; McKinstry, RC; Ratai, EM; Safriel, Y; Snyder, BS; Sorensen, AG; Zhang, Z, 2013) |
"Age and choline/creatine ratio are strong independent prognostic factors in high grade gliomas." | 3.81 | Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas. ( Kelekis, N; Kokakis, I; Kouloulias, V; Kouvaris, JR; Kyrgias, G; Mosa, E; Papathanasiou, M; Pissakas, G; Pistevou-Gombaki, K; Tolia, M; Tsoukalas, N; Verganelakis, D, 2015) |
" Primary central nervous system lymphoma (PCNSL) is a highly aggressive tumor responsive to high-dose methotrexate based regimens." | 3.73 | Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. ( Abrey, LE; DeAngelis, LM; Koutcher, JA; Lis, E; Panageas, KS; Raizer, JJ; Xu, S; Zakian, KL, 2005) |
"Seven patients responded to tamoxifen therapy (three with glioblastomas multiforme; four with anaplastic astrocytomas), and nine did not (six with glioblastomas multiforme; three with anaplastic astrocytomas)." | 3.70 | Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. ( Arnold, DL; Caramanos, Z; Langleben, A; LeBlanc, R; Preul, MC; Shenouda, G; Villemure, JG, 2000) |
"Postradiation treatment necrosis is one of the most serious late sequelae and appears within 6 months." | 3.01 | Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis. ( Aseel, A; McCarthy, P; Mohammed, A, 2023) |
"There were no significant adverse effects from FLT injected at a dose of 0." | 2.73 | NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies. ( Eary, JF; Hoffman, JM; Krohn, KA; Link, JM; Muzi, M; Spence, AM, 2008) |
"necrosis in patients with primary brain tumors or brain metastasis." | 2.53 | Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis. ( Chen, YC; Chuang, MT; Liu, YS; Tsai, YS; Wang, CK, 2016) |
"When MRS and MR imaging agree on prostate cancer presence, the positive predictive value is about 80-90%." | 2.44 | Proton MR spectroscopy of the prostate. ( Mueller-Lisse, UG; Scherr, MK, 2007) |
"This supports long-term HT in advanced prostate cancer." | 1.38 | Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. ( Bonomo, P; Clementi, V; D'Agostino, GR; Di Molfetta, IV; Gui, B; Mantini, G; Mattiucci, G; Valentini, AL, 2012) |
"The histological diagnosis was anaplastic oligodendroglioma (WHO grade III)." | 1.37 | [Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma]. ( Akutsu, H; Anno, I; Isobe, T; Masumoto, T; Matsumura, A; Nakai, K; Shiigai, M; Takano, S; Yamamoto, T, 2011) |
"Necrosis was present histologically in four of the five meningiomas classified either as atypical or papillary." | 1.30 | Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. ( Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Nakasu, S; Shino, A, 1999) |
"Thirteen cases of brain cancer treated by radiation therapy were examined by 1H magnetic resonance spectroscopy and gadolinium-enhanced T1-weighted magnetic resonance imaging and reexamined at 2-month intervals." | 1.29 | Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. ( Levendag, PC; Oudkerk, M; Sijens, PE; van Dijk, P; Vecht, CJ, 1995) |
"Surgical specimens of squamous cell carcinoma arising from the upper aerodigestive tract (n = 18) and from muscle (n = 13) were examined in vitro using high-field (11 T) proton MR spectroscopy." | 1.29 | Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. ( Blackstock, W; Castillo, M; Kwock, L; Mukherji, SK; Schiro, S; Shockley, W; Soper, R; Weissler, M, 1996) |
"A phase I trial and pharmacokinetic study of 5-aza-2'-deoxycytidine (5-aza-dCyd) were conducted in 21 patients with advanced solid tumors." | 1.27 | Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients. ( Gall, HE; Leyva, A; O'Brien, AM; Pinedo, HM; van Groeningen, CJ, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (5.13) | 18.7374 |
1990's | 8 (20.51) | 18.2507 |
2000's | 18 (46.15) | 29.6817 |
2010's | 9 (23.08) | 24.3611 |
2020's | 2 (5.13) | 2.80 |
Authors | Studies |
---|---|
Feng, A | 1 |
Yuan, P | 1 |
Huang, T | 1 |
Li, L | 1 |
Lyu, J | 1 |
Aseel, A | 1 |
McCarthy, P | 1 |
Mohammed, A | 1 |
Ratai, EM | 1 |
Zhang, Z | 1 |
Snyder, BS | 1 |
Boxerman, JL | 1 |
Safriel, Y | 1 |
McKinstry, RC | 1 |
Bokstein, F | 1 |
Gilbert, MR | 1 |
Sorensen, AG | 1 |
Barboriak, DP | 1 |
Deviers, A | 1 |
Ken, S | 1 |
Filleron, T | 1 |
Rowland, B | 1 |
Laruelo, A | 1 |
Catalaa, I | 1 |
Lubrano, V | 1 |
Celsis, P | 1 |
Berry, I | 1 |
Mogicato, G | 1 |
Cohen-Jonathan Moyal, E | 1 |
Laprie, A | 2 |
Tolia, M | 1 |
Verganelakis, D | 1 |
Tsoukalas, N | 1 |
Kyrgias, G | 1 |
Papathanasiou, M | 1 |
Mosa, E | 1 |
Kokakis, I | 1 |
Kouvaris, JR | 1 |
Pissakas, G | 1 |
Pistevou-Gombaki, K | 1 |
Kelekis, N | 1 |
Kouloulias, V | 1 |
Chuang, MT | 1 |
Liu, YS | 1 |
Tsai, YS | 1 |
Chen, YC | 1 |
Wang, CK | 1 |
Spence, AM | 1 |
Muzi, M | 1 |
Link, JM | 1 |
Hoffman, JM | 1 |
Eary, JF | 1 |
Krohn, KA | 1 |
Smith, EA | 2 |
Carlos, RC | 2 |
Junck, LR | 1 |
Tsien, CI | 1 |
Elias, A | 1 |
Sundgren, PC | 3 |
Matsusue, E | 1 |
Fink, JR | 1 |
Rockhill, JK | 1 |
Ogawa, T | 1 |
Maravilla, KR | 1 |
Goenka, AH | 1 |
Kumar, A | 1 |
Sharma, R | 1 |
Kirilova, A | 1 |
Damyanovich, A | 1 |
Crook, J | 1 |
Jezioranski, J | 1 |
Wallace, K | 1 |
Pintilie, M | 1 |
Isobe, T | 1 |
Akutsu, H | 1 |
Yamamoto, T | 1 |
Shiigai, M | 1 |
Masumoto, T | 1 |
Nakai, K | 1 |
Takano, S | 1 |
Anno, I | 1 |
Matsumura, A | 1 |
Elias, AE | 1 |
Frechtling, D | 1 |
George, B | 1 |
Maly, P | 2 |
Valentini, AL | 1 |
Gui, B | 1 |
D'Agostino, GR | 1 |
Mattiucci, G | 1 |
Clementi, V | 1 |
Di Molfetta, IV | 1 |
Bonomo, P | 1 |
Mantini, G | 1 |
Rock, JP | 1 |
Hearshen, D | 1 |
Scarpace, L | 1 |
Croteau, D | 1 |
Gutierrez, J | 1 |
Fisher, JL | 1 |
Rosenblum, ML | 1 |
Mikkelsen, T | 1 |
Mueller-Lisse, UG | 2 |
Scherr, M | 1 |
BRANDSTETTER, F | 1 |
GITSCH, E | 1 |
SCHULLER, E | 1 |
Lichy, MP | 1 |
Bachert, P | 1 |
Henze, M | 1 |
Lichy, CM | 1 |
Debus, J | 1 |
Schlemmer, HP | 1 |
Ando, K | 1 |
Ishikura, R | 1 |
Nagami, Y | 1 |
Morikawa, T | 1 |
Takada, Y | 1 |
Ikeda, J | 1 |
Nakao, N | 1 |
Matsumoto, T | 1 |
Arita, N | 1 |
Chan, AA | 1 |
Lau, A | 1 |
Pirzkall, A | 2 |
Chang, SM | 1 |
Verhey, LJ | 1 |
Larson, D | 2 |
McDermott, MW | 1 |
Dillon, WP | 3 |
Nelson, SJ | 3 |
Plotkin, M | 1 |
Eisenacher, J | 1 |
Bruhn, H | 1 |
Wurm, R | 1 |
Michel, R | 1 |
Stockhammer, F | 1 |
Feussner, A | 1 |
Dudeck, O | 1 |
Wust, P | 1 |
Felix, R | 1 |
Amthauer, H | 1 |
Raizer, JJ | 1 |
Koutcher, JA | 1 |
Abrey, LE | 1 |
Panageas, KS | 1 |
DeAngelis, LM | 1 |
Lis, E | 1 |
Xu, S | 1 |
Zakian, KL | 1 |
Haas-Kogan, DA | 1 |
Cha, S | 1 |
Banerjee, A | 1 |
Le, TP | 1 |
Lu, Y | 1 |
Nelson, S | 1 |
McKnight, TR | 1 |
Weybright, P | 1 |
Hassan, DG | 1 |
Nan, B | 1 |
Rohrer, S | 1 |
Junck, L | 1 |
Zeng, QS | 1 |
Li, CF | 1 |
Zhang, K | 1 |
Liu, H | 2 |
Kang, XS | 1 |
Zhen, JH | 1 |
Scherr, MK | 1 |
Sijens, PE | 1 |
Vecht, CJ | 1 |
Levendag, PC | 1 |
van Dijk, P | 1 |
Oudkerk, M | 1 |
Mukherji, SK | 1 |
Schiro, S | 1 |
Castillo, M | 1 |
Kwock, L | 1 |
Soper, R | 1 |
Blackstock, W | 1 |
Shockley, W | 1 |
Weissler, M | 1 |
Tedeschi, G | 1 |
Lundbom, N | 1 |
Raman, R | 1 |
Bonavita, S | 1 |
Duyn, JH | 1 |
Alger, JR | 2 |
Di Chiro, G | 1 |
Wald, LL | 1 |
Day, MR | 1 |
Noworolski, SE | 1 |
Henry, RG | 1 |
Huhn, SL | 1 |
Chang, S | 2 |
Prados, MD | 2 |
Sneed, PK | 2 |
Larson, DA | 1 |
Wara, WM | 1 |
McDermott, M | 2 |
Gutin, PH | 1 |
Vigneron, DB | 2 |
Kinoshita, K | 1 |
Tada, E | 1 |
Matsumoto, K | 1 |
Asari, S | 1 |
Ohmoto, T | 1 |
Itoh, T | 1 |
Burtscher, IM | 1 |
Ståhlberg, F | 1 |
Holtås, S | 1 |
Lazareff, JA | 1 |
Bockhorst, KH | 1 |
Curran, J | 1 |
Olmstead, C | 1 |
Shino, A | 1 |
Nakasu, S | 1 |
Matsuda, M | 1 |
Handa, J | 1 |
Morikawa, S | 1 |
Inubushi, T | 1 |
Preul, MC | 1 |
Caramanos, Z | 1 |
Villemure, JG | 1 |
Shenouda, G | 1 |
LeBlanc, R | 1 |
Langleben, A | 1 |
Arnold, DL | 1 |
Graves, EE | 1 |
Chin, C | 1 |
Verhey, L | 1 |
Lamborn, K | 1 |
Ricci, PE | 1 |
Pitt, A | 1 |
Keller, PJ | 1 |
Coons, SW | 1 |
Heiserman, JE | 1 |
Hall, WA | 1 |
Martin, AJ | 1 |
Truwit, CL | 1 |
van Groeningen, CJ | 1 |
Leyva, A | 1 |
O'Brien, AM | 1 |
Gall, HE | 1 |
Pinedo, HM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy Using [F18] Fluorothymidine (FLT) As a Marker of Proliferation in Patients With Primary Brain Tumors[NCT00276770] | 12 participants (Actual) | Interventional | 2006-02-28 | Completed | |||
Multi-paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases[NCT04626206] | 12 participants (Anticipated) | Observational | 2020-12-31 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 reviews available for creatine and Local Neoplasm Recurrence
Article | Year |
---|---|
Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Cr | 2023 |
Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
Topics: Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Hum | 2016 |
[1H magnetic resonance spectroscopy of the prostate].
Topics: Biopsy; Choline; Citrates; Creatine; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Magnetic | 2003 |
Proton MR spectroscopy of the prostate.
Topics: Biopsy; Choline; Citric Acid; Creatine; Diagnosis, Differential; Humans; Imaging, Three-Dimensional; | 2007 |
4 trials available for creatine and Local Neoplasm Recurrence
Article | Year |
---|---|
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Be | 2013 |
Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Crea | 2014 |
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
Topics: Adult; Biomarkers; Carbon Dioxide; Cell Proliferation; Creatine; Dideoxynucleosides; Drug-Related Si | 2008 |
Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Fema | 2007 |
31 other studies available for creatine and Local Neoplasm Recurrence
Article | Year |
---|---|
Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
Topics: Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; | 2022 |
Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas.
Topics: Adult; Age Factors; Aged; Choline; Creatine; Disease-Free Survival; Female; Glioma; Humans; Magnetic | 2015 |
Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast | 2009 |
Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Choline; Cr | 2010 |
MR spectroscopy for differentiation of recurrent glioma from radiation-induced changes.
Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast | 2009 |
3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
Topics: Brachytherapy; Choline; Citric Acid; Creatine; Humans; Iodine Radioisotopes; Magnetic Resonance Imag | 2011 |
[Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
Topics: Adult; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; F | 2011 |
MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Diagn | 2011 |
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Choline; Combined Moda | 2012 |
Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
Topics: Adult; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glioma; Humans; Lactic Acid; Lip | 2002 |
[Effects of vitamin E on kreatinin metabolism in recurrent female genital carcinoma].
Topics: Carcinoma; Creatine; Female; Genitalia; Genitalia, Female; Humans; Neoplasm Recurrence, Local; Neopl | 1955 |
Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Astrocytoma; Brain Neoplasms; | 2004 |
[Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Female; Glioma | 2004 |
Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Cohor | 2004 |
123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
Topics: Adult; Aged; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Female; Glioblastoma; Huma | 2004 |
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aspartic Acid; Central Nervous Syst | 2005 |
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Topics: Aspartic Acid; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Disease Progression | 2005 |
Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast Media; | 2005 |
Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast.
Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Follow-Up Studies; Four | 1995 |
Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics.
Topics: Carcinoma, Squamous Cell; Choline; Confidence Intervals; Creatine; Esophageal Neoplasms; Esophagus; | 1996 |
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplas | 1997 |
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
Topics: Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Disease Pro | 1997 |
Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy.
Topics: Adult; Animals; Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Cranial Irradiation; | 1997 |
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo | 1997 |
Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging.
Topics: Adolescent; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Cell Division; Child; Child, Prescho | 1998 |
Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Topics: Adult; Aged; Aged, 80 and over; Antigens, Nuclear; Biomarkers, Tumor; Brain; Cell Division; Cell Tra | 1999 |
Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Astro | 2000 |
A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.
Topics: Adult; Aged; Aspartic Acid; Astrocytoma; Choline; Creatine; Female; Glioblastoma; Humans; Lactic Aci | 2000 |
Effect of voxel position on single-voxel MR spectroscopy findings.
Topics: Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glio | 2000 |
An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Biopsy; Brain; Brain Mapping; Brain Neop | 2001 |
Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients.
Topics: Adult; Aged; Azacitidine; Creatine; Decitabine; Dose-Response Relationship, Drug; Drug Administratio | 1986 |